Figure 2. Relationship between LCK metagene gene score and prognosis and gene mutation in endometrial cancer. (A) Survival curves for endometrioid endometrial adenocarcinoma indicated that high expression of LCK metagene correlates with better clinical outcomes. (B) Survival curves for serous endometrial adenocarcinoma. (C) Survival curves for mixed serous and endometrioid. Data were analyzed in KM plotter. (D) LCK metagene scores of patients with different subtypes of endometrial cancer. (E) Somatic mutation data of PTEN, PIK3CA, TP53, and KRAS. Mut: mutant; WT: wild-type. Data are presented as the mean ± SEM. *P < 0.05, ** P < 0.01, *** P < 0.001.